These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11990900)

  • 1. Successful treatment of steroid-induced depression with low dosage of fluvoxamine.
    Yoshimura R; Ueda N; Nakamura J
    Aust N Z J Psychiatry; 2001 Dec; 35(6):855-6. PubMed ID: 11990900
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report.
    Cayköylü A; Albayrak Y; Uğurlu GK; Ekinci O
    Acta Neurol Belg; 2011 Mar; 111(1):62-5. PubMed ID: 21510237
    [No Abstract]   [Full Text] [Related]  

  • 3. When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
    Schaller JL; Behar D; Chamberlain T
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):111-3. PubMed ID: 9547477
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluvoxamine (fevarin) in the treatment of depression].
    Sheĭfer MS; Tsybina MI; Davydenko MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):64-7. PubMed ID: 11195542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluvoxamine (fevarin) in psychogenic depression].
    Dubnitskaia EB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(12):48-50. PubMed ID: 11811127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antidepressants.
    Kupecz D
    Nurse Pract; 1995 Sep; 20(9):64-7. PubMed ID: 7501318
    [No Abstract]   [Full Text] [Related]  

  • 7. An open-label pilot study of fluvoxamine for mixed anxiety-depression.
    Houck C
    Psychopharmacol Bull; 1998; 34(2):225-7. PubMed ID: 9641005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.
    Jakob F; Wolf J
    Pharmacopsychiatry; 2007 May; 40(3):129. PubMed ID: 17541891
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluvoxamine-methadone interaction.
    Alderman CP; Frith PA
    Aust N Z J Psychiatry; 1999 Feb; 33(1):99-101. PubMed ID: 10197892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects.
    Grassi B; Gambini O; Scarone S
    Pharmacopsychiatry; 1995 May; 28(3):93-4. PubMed ID: 7568371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year follow-up study of sertraline and fluvoxamine in long-term treatment of unipolar subjects with high recurrence rate.
    Franchini L; Gasperini M; Zanardi R; Smeraldi E
    J Affect Disord; 2000 Jun; 58(3):233-6. PubMed ID: 10802132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant response and fluvoxamine plasma concentrations: a pilot study.
    Schwarzenbach F; Netillard C; Demoly P; Bisschop D; Limat S; Bouquet S; Vandel S; Bel AM; Woronoff-Lemsi MC
    Pharm World Sci; 2003 Feb; 25(1):27-9. PubMed ID: 12661474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic findings during extended clinical trials of fluvoxamine in depression: one years experience.
    Hochberg HM; Kanter D; Houser VP
    Pharmacopsychiatry; 1995 Nov; 28(6):253-6. PubMed ID: 8773292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful electroconvulsive therapy in major depression with fluvoxamine-induced bruxism.
    Miyaoka T; Yasukawa R; Mihara T; Shimizu Y; Tsubouchi K; Maeda T; Mizuno S; Uegaki J; Inagaki T; Horiguchi J; Tachibana H
    J ECT; 2003 Sep; 19(3):170-2. PubMed ID: 12972988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear pharmacokinetics of fluvoxamine and gender differences.
    Härtter S; Wetzel H; Hammes E; Torkzadeh M; Hiemke C
    Ther Drug Monit; 1998 Aug; 20(4):446-9. PubMed ID: 9712472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
    Conus P; Bondolfi G; Eap CB; Macciardi F; Baumann P
    Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study.
    Terra JL; Montgomery SA
    Int Clin Psychopharmacol; 1998 Mar; 13(2):55-62. PubMed ID: 9669185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trial.
    Härtter S; Wetzel H; Hammes E; Torkzadeh M; Hiemke C
    Pharmacopsychiatry; 1998 Sep; 31(5):199-200. PubMed ID: 9832352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
    Lopukhov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.